JP4522586B2 - 新規のベンゾフラン誘導体、それらの製造方法及び薬剤としてのそれらの使用 - Google Patents
新規のベンゾフラン誘導体、それらの製造方法及び薬剤としてのそれらの使用 Download PDFInfo
- Publication number
- JP4522586B2 JP4522586B2 JP2000583898A JP2000583898A JP4522586B2 JP 4522586 B2 JP4522586 B2 JP 4522586B2 JP 2000583898 A JP2000583898 A JP 2000583898A JP 2000583898 A JP2000583898 A JP 2000583898A JP 4522586 B2 JP4522586 B2 JP 4522586B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- formula
- amino
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- ZSBLNBPXXOIVRR-UHFFFAOYSA-N CC(C)(C)OC(C(Cc1cc2cc(CCC(OC)=O)ccc2[o]1)NC(OCc1ccccc1)=O)=O Chemical compound CC(C)(C)OC(C(Cc1cc2cc(CCC(OC)=O)ccc2[o]1)NC(OCc1ccccc1)=O)=O ZSBLNBPXXOIVRR-UHFFFAOYSA-N 0.000 description 1
- TVSMLBGFGKLKOO-UHFFFAOYSA-N CC1CCN(C)CC1 Chemical compound CC1CCN(C)CC1 TVSMLBGFGKLKOO-UHFFFAOYSA-N 0.000 description 1
- NMILGIZTAZXMTM-UHFFFAOYSA-N CCCN1CCOCC1 Chemical compound CCCN1CCOCC1 NMILGIZTAZXMTM-UHFFFAOYSA-N 0.000 description 1
- OUJQCNUNCYSQEO-UHFFFAOYSA-N OC(C(Cc1cc(cc(CCC(NC2=NCCCN2)=O)cc2)c2[o]1)NS(NCc1ccccc1)(=O)=O)=O Chemical compound OC(C(Cc1cc(cc(CCC(NC2=NCCCN2)=O)cc2)c2[o]1)NS(NCc1ccccc1)(=O)=O)=O OUJQCNUNCYSQEO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR98/14779 | 1998-11-24 | ||
| FR9814779A FR2786184B1 (fr) | 1998-11-24 | 1998-11-24 | Nouveaux derives du benzofurane, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| PCT/FR1999/002879 WO2000031070A1 (fr) | 1998-11-24 | 1999-11-23 | Nouveaux derives du benzofurane, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002530403A JP2002530403A (ja) | 2002-09-17 |
| JP2002530403A5 JP2002530403A5 (cg-RX-API-DMAC7.html) | 2006-12-14 |
| JP4522586B2 true JP4522586B2 (ja) | 2010-08-11 |
Family
ID=9533118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000583898A Expired - Lifetime JP4522586B2 (ja) | 1998-11-24 | 1999-11-23 | 新規のベンゾフラン誘導体、それらの製造方法及び薬剤としてのそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6458801B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1133491B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4522586B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE232859T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69905490T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2192870T3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2786184B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000031070A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1176145A1 (en) * | 2000-07-28 | 2002-01-30 | Aventis Pharma Deutschland GmbH | Novel guanidino derivatives as inhibitors of cell adhesion |
| US7078541B2 (en) * | 2002-02-07 | 2006-07-18 | Galileo Pharmaceuticals, Inc. | Benzofuran derivatives |
| US6653346B1 (en) * | 2002-02-07 | 2003-11-25 | Galileo Pharmaceuticals, Inc. | Cytoprotective benzofuran derivatives |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU675680B2 (en) * | 1992-10-14 | 1997-02-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| GB9408577D0 (en) * | 1994-04-29 | 1994-06-22 | Fujisawa Pharmaceutical Co | New compound |
| ATE227567T1 (de) * | 1994-05-27 | 2002-11-15 | Merck & Co Inc | Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption |
| GB9522007D0 (en) * | 1995-10-27 | 1996-01-03 | Fujisawa Pharmaceutical Co | New compound |
| US5955495A (en) * | 1996-05-03 | 1999-09-21 | Hoffmann-La Roche Inc. | Method of treating diseases of the CNS |
| GB9614347D0 (en) * | 1996-07-09 | 1996-09-04 | Smithkline Beecham Spa | Novel compounds |
| DE19629816A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| US5981514A (en) * | 1998-02-12 | 1999-11-09 | Somberg; John C. | (N-alkyl-N-hydroxymethylamino)alkoxybenzoylbenzofurans and the phosphate esters thereof |
-
1998
- 1998-11-24 FR FR9814779A patent/FR2786184B1/fr not_active Expired - Lifetime
-
1999
- 1999-11-23 DE DE69905490T patent/DE69905490T2/de not_active Expired - Lifetime
- 1999-11-23 US US09/856,542 patent/US6458801B1/en not_active Expired - Lifetime
- 1999-11-23 ES ES99956121T patent/ES2192870T3/es not_active Expired - Lifetime
- 1999-11-23 WO PCT/FR1999/002879 patent/WO2000031070A1/fr not_active Ceased
- 1999-11-23 EP EP99956121A patent/EP1133491B1/fr not_active Expired - Lifetime
- 1999-11-23 JP JP2000583898A patent/JP4522586B2/ja not_active Expired - Lifetime
- 1999-11-23 AT AT99956121T patent/ATE232859T1/de not_active IP Right Cessation
-
2002
- 2002-06-26 US US10/180,253 patent/US6586442B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE232859T1 (de) | 2003-03-15 |
| DE69905490D1 (de) | 2003-03-27 |
| EP1133491A1 (fr) | 2001-09-19 |
| US6586442B2 (en) | 2003-07-01 |
| EP1133491B1 (fr) | 2003-02-19 |
| US6458801B1 (en) | 2002-10-01 |
| US20020187976A1 (en) | 2002-12-12 |
| FR2786184A1 (fr) | 2000-05-26 |
| WO2000031070A1 (fr) | 2000-06-02 |
| JP2002530403A (ja) | 2002-09-17 |
| FR2786184B1 (fr) | 2002-09-20 |
| DE69905490T2 (de) | 2003-07-24 |
| ES2192870T3 (es) | 2003-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6492356B1 (en) | Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists | |
| US6660728B2 (en) | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists | |
| AU752882B2 (en) | Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion | |
| AU768206B2 (en) | Novel guanidine derivatives as inhibitors of cell adhesion | |
| JP4550286B2 (ja) | 新規なアシルグアニジン誘導体、それらの製造方法、薬剤としてのそれらの使用及びそれらを含有する製薬組成物 | |
| JP5143989B2 (ja) | ビトロネクチン受容体の新規な拮抗薬誘導体 | |
| US6458801B1 (en) | Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same | |
| JP2003532732A5 (cg-RX-API-DMAC7.html) | ||
| JP4578685B2 (ja) | イミノグアニジン誘導体、それらの製造方法及び薬剤としてのそれらの使用 | |
| US6762190B2 (en) | Thienylalanine derivatives as inhibitors of cell adhesion | |
| CZ20002672A3 (cs) | Sulfonamidové deriváty jako inhibitory kostní resorpce a jako inhibitory buněčné adheze |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061017 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061017 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091124 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091125 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100223 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20100223 |
|
| RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20100223 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100223 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100427 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100526 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4522586 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130604 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |